The Australian government has announced significant funding of $53.6 million towards advancing research in women’s health, chronic pain management, and alcohol use under the 2024 Medical Research Future Fund (MRFF). This funding initiative, part of the Emerging Priorities and Consumer-Driven Research initiative, aims to address critical gaps in healthcare through targeted research grants.
The 2024 Infertility, Pregnancy Loss and Menopause grant opportunity will allocate up to $25 million to investigate key areas such as the impacts of fertility treatments, development of new predictive markers for pregnancy loss, and the effects of perimenopause and menopause on women’s health.
Additionally, the 2024 Novel Treatments and Management Strategies for Chronic Pain grant opportunity will dedicate $8.6 million to projects focusing on chronic pain management. This includes research into chronic pain resulting from injuries, chronic pelvic pain, endometriosis-related pain, and other forms of chronic pain affecting women.
Moreover, the 2024 Alcohol and Other Drugs grant opportunity will provide $20 million for research aimed at understanding the impact of alcohol consumption on the physical and mental health of First Nations individuals, adolescents, and young adults. This grant also supports studies on the effects of alcohol and polysubstance use within these demographics, as well as patient-centred approaches for treating substance use disorders among First Nations communities, adolescents, young adults, and women. Furthermore, research into effective pain management for individuals with substance use disorders will be supported.
Interested researchers and organizations are encouraged to visit GrantConnect and the MRFF calendar for detailed information on these and other MRFF grant opportunities.
This funding initiative underscores Australia’s commitment to advancing healthcare research that addresses pressing health issues affecting women, individuals living with chronic pain, and those impacted by substance use disorders across diverse demographics.